Das vorliegende Dokument ist eine Neufassung und Aktualisierung der Leitlinie zur
Diagnostik und Therapie von Patienten mit COPD, die die bisherige Version aus dem Jahr …

Sarcoidosis is a systemic disease of unknown etiology characterized by the presence of
noncaseating granulomas in any organ, most commonly the lungs and intrathoracic lymph …

Despite the development of pharmacological therapies that are effective in slowing the
progression of idiopathic pulmonary fibrosis (IPF), it remains a debilitating and lethal …

Pulmonary complications in CTD are common and can involve the interstitium, airways,
pleura and pulmonary vasculature. ILD can occur in all CTD (CTD‐ILD), and may vary from …

Background COPD is a leading cause of mortality. Research Question We hypothesized that
applying machine learning to clinical and quantitative CT imaging features would improve …

Rationale: Exploration of FVC as it relates to mortality in idiopathic pulmonary fibrosis (IPF),
a chronic, progressive, and ultimately fatal parenchymal lung disease, is important both …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease with high mortality that
commonly occurs in middle-aged and older adults. IPF, characterized by a decline in lung …

Idiopathic pulmonary fibrosis (IPF) is an advancing and fatal lung disease with increasing
incidence and prevalence. Nintedanib and pirfenidone were approved by the FDA for the …

The selection of appropriate recipients for lung transplantation is an evolving discipline. As
experience with the procedure has developed over the last decades, the identification of …

Pulmonary hypertension (PH) is known to complicate various forms of interstitial lung
disease (ILD), including idiopathic pulmonary fibrosis, the interstitial pneumonias and …